Trillium Asset Management LLC Purchases New Stake in Ingevity Corporation $NGVT

Trillium Asset Management LLC purchased a new stake in shares of Ingevity Corporation (NYSE:NGVT) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 92,450 shares of the company’s stock, valued at approximately $6,903,000.

Several other institutional investors also recently bought and sold shares of NGVT. Global Retirement Partners LLC acquired a new stake in shares of Ingevity in the fourth quarter worth $27,000. Meeder Asset Management Inc. acquired a new position in shares of Ingevity during the 4th quarter valued at $33,000. Geneos Wealth Management Inc. boosted its position in Ingevity by 85.8% during the 2nd quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after purchasing an additional 387 shares during the period. Frazier Financial Advisors LLC purchased a new stake in Ingevity during the 2nd quarter worth $37,000. Finally, Headlands Technologies LLC acquired a new stake in Ingevity in the 2nd quarter valued at $46,000. 91.59% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, SVP Terrance M. Dyer sold 496 shares of Ingevity stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $68.49, for a total transaction of $33,971.04. Following the sale, the senior vice president directly owned 7,202 shares of the company’s stock, valued at approximately $493,264.98. The trade was a 6.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Ryan C. Fisher sold 2,709 shares of Ingevity stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $73.72, for a total value of $199,707.48. Following the sale, the senior vice president directly owned 15,722 shares in the company, valued at approximately $1,159,025.84. The trade was a 14.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 18,297 shares of company stock worth $1,381,452 over the last ninety days. Corporate insiders own 0.88% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have commented on NGVT shares. Wall Street Zen cut Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 1st. Weiss Ratings upgraded Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a report on Friday, July 31st. Two research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $80.00.

Ingevity Price Performance

Shares of NGVT stock opened at $69.54 on Friday. The firm has a fifty day simple moving average of $73.88 and a 200-day simple moving average of $71.84. The company has a market capitalization of $2.39 billion, a PE ratio of 47.31 and a beta of 1.16. Ingevity Corporation has a twelve month low of $45.85 and a twelve month high of $79.29. The company has a current ratio of 1.61, a quick ratio of 1.15 and a debt-to-equity ratio of 22.52.

Ingevity (NYSE:NGVT) last released its quarterly earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.41. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. The firm had revenue of $314.10 million for the quarter, compared to the consensus estimate of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Equities research analysts anticipate that Ingevity Corporation will post 5.4 earnings per share for the current fiscal year.

About Ingevity

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.